Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose ketamine plus morphine for pain control in multiple trauma patients
IRCT20180129038549N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketamine and morphine in acute pain (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Severity of pain before and after injection. Started Oct 2017; status: completed.
02
Drugs
ketaminemorphine
03
Conditions
acute pain
Beyond the preview
Go deeper on IRCT20180129038549N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180129038549N3.